Genomic and transcriptome profiling identified both human and HBV genetic variations and their interactions in Chinese hepatocellular carcinoma

被引:8
作者
Dong, Hua [1 ]
Qian, Ziliang [1 ]
Zhang, Lan [2 ]
Chen, Yunqin [3 ]
Ren, Zhenggang [2 ]
Ji, Qunsheng [1 ]
机构
[1] AstraZeneca Asian & Emerging Market iMed, Zhangjiang Hitech Pk, Shanghai, Peoples R China
[2] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China
[3] AstraZeneca, R&D Informat, Shanghai, Peoples R China
关键词
aCGH; RNASeq; HBV; HCC;
D O I
10.1016/j.gdata.2015.07.018
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Interaction between HBV and host genome integrations in hepatocellular carcinoma (HCC) development is a complex process and the mechanism is still unclear. Here we described in details the quality controls and data mining of aCGH and transcriptome sequencing data on 50 HCC samples from the Chinese patients, published by Dong et al. (2015) (GEO#: GSE65486). In additional to the HBV-MLL4 integration discovered, we also investigated the genetic aberrations of HBV and host genes as well as their genetic interactions. We reported human genome copy number changes and frequent transcriptome variations (e.g. TP53, CTNNB1 mutation, especially MLL family mutations) in this cohort of the patients. For HBV genotype C, we identified a novel linkage disequilibrium region covering HBV replication regulatory elements, including basal core promoter, DR1, epsilon and poly-A regions, which is associated with HBV core antigen over-expression and almost exclusive to HBV-MLL4 integration. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1 / 3
页数:3
相关论文
共 10 条
[1]   Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma [J].
Dong, Hua ;
Zhang, Lan ;
Qian, Ziliang ;
Zhu, Xuehua ;
Zhu, Guanshan ;
Chen, Yunqin ;
Xie, Xiaoying ;
Ye, Qinghai ;
Zang, Jie ;
Ren, Zhenggang ;
Ji, Qunsheng .
PLOS ONE, 2015, 10 (04)
[2]   CURRENT CONCEPTS Hepatocellular Carcinoma [J].
El-Serag, Hashem B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1118-1127
[3]   HBV A1762T, G1764A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study [J].
Fang, Zhong-Liao ;
Sabin, Caroline A. ;
Dong, Bai-Qing ;
Ge, Lian-Ying ;
Wei, Shao-Chao ;
Chen, Qin-Yan ;
Fang, Kong-Xiong ;
Yang, Jin-Ye ;
Wang, Xue-Yan ;
Harrison, Tim J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (09) :2254-2262
[4]   Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma [J].
Guichard, Cecile ;
Amaddeo, Giuliana ;
Imbeaud, Sandrine ;
Ladeiro, Yannick ;
Pelletier, Laura ;
Ben Maad, Ichrafe ;
Calderaro, Julien ;
Bioulac-Sage, Paulette ;
Letexier, Melanie ;
Degos, Francoise ;
Clement, Bruno ;
Balabaud, Charles ;
Chevet, Eric ;
Laurent, Alexis ;
Couchy, Gabrielle ;
Letouze, Eric ;
Calvo, Fabien ;
Zucman-Rossi, Jessica .
NATURE GENETICS, 2012, 44 (06) :694-U120
[5]   OSA: a fast and accurate alignment tool for RNA-Seq [J].
Hu, Jun ;
Ge, Huanying ;
Newman, Matt ;
Liu, Kejun .
BIOINFORMATICS, 2012, 28 (14) :1933-1934
[6]   Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma [J].
Huang, Jian ;
Deng, Qing ;
Wang, Qun ;
Li, Kun-Yu ;
Dai, Ji-Hong ;
Li, Niu ;
Zhu, Zhi-Dong ;
Zhou, Bo ;
Liu, Xiao-Yan ;
Liu, Rui-Fang ;
Fei, Qian-Lan ;
Chen, Hui ;
Cai, Bing ;
Zhou, Boping ;
Xiao, Hua-Sheng ;
Qin, Lun-Xiu ;
Han, Ze-Guang .
NATURE GENETICS, 2012, 44 (10) :1117-+
[7]   Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection [J].
Lee, Jong-Han ;
Han, Kwang-Hyub ;
Lee, Jae Myun ;
Park, Jeon Han ;
Kim, Hyon-Suk .
CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (06) :914-921
[8]   Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis [J].
Liu, Shijian ;
Zhang, Hongwei ;
Gu, Chunying ;
Yin, Jianhua ;
He, Yongchao ;
Xie, Jiaxin ;
Cao, Guangwen .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15) :1066-1082
[9]   Wnt/beta-Catenin Signaling and Small Molecule Inhibitors [J].
Voronkov, Andrey ;
Krauss, Stefan .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (04) :634-664
[10]   Targeting p53 for novel anticancer therapy [J].
Wang, Zhen ;
Sun, Yi .
TRANSLATIONAL ONCOLOGY, 2010, 3 (01) :1-12